kanamycin a has been researched along with phenylalanine arginine beta-naphthylamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohnert, JA; Karamian, B; Nikaido, H | 1 |
| Deering, RW; Mincer, TJ; Poulson-Ellestad, KL; Rowley, DC; Whalen, KE | 1 |
2 other study(ies) available for kanamycin a and phenylalanine arginine beta-naphthylamide
| Article | Year |
|---|---|
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Enhancement of antibiotic activity against multidrug-resistant bacteria by the efflux pump inhibitor 3,4-dibromopyrrole-2,5-dione isolated from a Pseudoalteromonas sp.
Topics: Anti-Bacterial Agents; Benzimidazoles; Drug Resistance, Multiple; Fluorescent Dyes; Gram-Negative Bacteria; Membrane Transport Proteins; Metabolomics; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Pseudoalteromonas; Pseudomonas aeruginosa; Pyrroles | 2015 |